AMGN241220C255000
- 13.49
- -4.48-24.93%
Amgen Newsroom
Tuesday, Tech Pulls Back, While Traders Await FOMC Rate | Wall Street Today
Honeywell's Quantum-computing Business Could Be Worth $20 Billion
Tuesday Tech Pull Back After Nasdaq and Bitcoin Record | Live Stock
UBS Cuts Price Target on Amgen to $280 From $326, Maintains Neutral Rating
Is Amgen Inc. (AMGN) the Best Weight Loss Stock to Buy Now According to Hedge Funds?
Another Week, Another Index Record | Lkive Stock
Those Who Invested in Amgen (NASDAQ:AMGN) Three Years Ago Are up 34%
Weekly Buzz: Tech stocks hit high scores on ominous day
Dow's 112-Point Fall Led By Losses In NVIDIA Corp., Amgen Shares
Drug Price Hikes Unsupported By Evidence Cost US $815 Million: ICER Report
Express News | "Weight-Loss Drug Craze Appears To Be Curbing U.S. Obesity Epidemic; Obesity Is Down In The U.S. For The First Time In A Decade. A New Study Suggests Weight-Loss Drugs May Explain Why" - Bloomberg News
Market Mixed on Friday the 13th | Livestock
Thursday Ends in Index Declines | Wall Street Today
Unpacking the Latest Options Trading Trends in Amgen
Market Falls Thursday, Producer Inflation Grows, and Tech Pulls Back From Records | LiveStock
Why Amgen Inc. (AMGN) Is the Best Safe Stock to Buy According to Analysts?
Amgen To Go Ex-Dividend On February 14th, 2025 With 2.38 USD Dividend Per Share
10 Health Care Stocks Whale Activity In Today's Session
Market Climbs on CPI Inflation and Likelihood of Rate Cuts | Livestock
Oppenheimer Maintains Amgen(AMGN.US) With Buy Rating, Maintains Target Price $380